# Study of LUCAR-20S in Patients With R/R NHL

> **NCT04176913** · PHASE1 · TERMINATED · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 7 (actual)

## Conditions studied

- Diffuse Large B Cell Lymphoma
- Follicular Lymphoma
- Mantle Cell Lymphoma
- Small Lymphocytic Lymphoma

## Interventions

- **DRUG:** LUCAR-20S CAR-T cells

## Key facts

- **NCT ID:** NCT04176913
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-12-01
- **Primary completion:** 2021-12-09
- **Final completion:** 2021-12-09
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Both the sponsors and collaborator are considering terminating the study
- **Last updated:** 2022-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04176913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04176913, "Study of LUCAR-20S in Patients With R/R NHL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04176913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*